Ignite Creation Date:
2024-05-06 @ 2:12 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04249739
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-03-13
First Post:
2020-01-21
Brief Title:
Pembrolizumab CapecitabineOxaliplatin CapeOx -HER2 Nagative and Pembrolizumab Trastuzumab CisplatinCapecitabine HER2 Positive
Sponsor:
Organization:
Samsung Medical Center